Max14 Jan 2026 14:29
Well said
It's utter obsession some have
One large deal blows everything wide open
[ ] Key growth/CAGR markets which PYC operate
MMID 18% CAGR with market set to be $13bln
Bio Statistics 24% CAGR $40bln market
Regulatory authorities across the world require robust biometrics practices to approve new drugs. Biometrics typically incorporates three main areas:
1. Biostatistics: Supporting the design of clinical studies and analysis of resulting data
2. Statistical Programming: Use of programming language to process, analyse and visualise clinical data
3. Data Management: Setup and oversight of the collection, entry, and validation of clinical trial data
Personalised medicine 7.5% CAGR and largest market is North America ( partner DoseMeRx based there)
General overviews
Total Income at 3yr high and bolstered by moving into new therapeutic areas such as immunology and cardiovascular
Just after year end received £250,000 + and will recieve £60k grant, therefore cash position as of July was almost £800,000
Have applied for other grants and will announce if/when progressed
Conversion rate 2022-2024 was 27%
Conversation rate 2025 jumped to 45%
6 late stage contracts due ( some of which announced Dec 2025)